Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity	ALG10B ALG10	5.16e-05	2	144	2	GO:0106073
GeneOntologyMolecularFunction	alpha-L-arabinofuranosidase activity	OTOGL OTOG	5.16e-05	2	144	2	GO:0046556
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	ROCK2 KALRN TRPM7 RIPK4 ALPK1 CIT GRK2 MYLK3 STRADA LTBP1 MAP2K2 RSKR	9.65e-05	446	144	12	GO:0004674
GeneOntologyMolecularFunction	protein kinase activity	ROCK2 KALRN TRPM7 ROR2 RIPK4 ALPK1 CIT GRK2 MYLK3 STRADA LTBP1 FGR MAP2K2 RSKR	1.15e-04	600	144	14	GO:0004672
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	ROCK2 KALRN TRPM7 POLE ROR2 RIPK4 ALPK1 CIT GRK2 MYLK3 TAMM41 STRADA LTBP1 XYLB FGR POLQ MAP2K2 RSKR	1.45e-04	938	144	18	GO:0016772
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	ROCK2 KALRN TRPM7 ROR2 RIPK4 ALPK1 CIT GRK2 MYLK3 STRADA LTBP1 XYLB FGR MAP2K2 RSKR	1.90e-04	709	144	15	GO:0016773
GeneOntologyMolecularFunction	kinase activity	ROCK2 KALRN TRPM7 ROR2 RIPK4 ALPK1 CIT GRK2 MYLK3 STRADA LTBP1 XYLB FGR MAP2K2 RSKR	4.21e-04	764	144	15	GO:0016301
GeneOntologyMolecularFunction	glucosyltransferase activity	UGGT1 ALG10B ALG10	5.12e-04	22	144	3	GO:0046527
GeneOntologyBiologicalProcess	arabinose metabolic process	OTOGL OTOG	4.71e-05	2	142	2	GO:0019566
GeneOntologyBiologicalProcess	vibrational conductance of sound to the inner ear	OTOGL OTOG	4.71e-05	2	142	2	GO:0055127
GeneOntologyBiologicalProcess	L-arabinose metabolic process	OTOGL OTOG	4.71e-05	2	142	2	GO:0046373
Domain	Alg10	ALG10B ALG10	5.58e-05	2	140	2	IPR016900
Domain	DIE2_ALG10	ALG10B ALG10	5.58e-05	2	140	2	PF04922
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ATRN LDLRAP1 USP34 RELN WAPL ERG KALRN TRPM7 PEG3 RAPGEF4 RIPK4 DNAAF9 CIT PDLIM5 ZNF181 RYR3 MICU1 ADAMTS9 NETO1 NFE2L2 SGSM2 SMARCE1 KLHL4	4.55e-09	1285	146	23	35914814
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CUL4A GBF1 TRPM7 DOCK11 NELFCD ROR2 ALPK1 DDX1 PLEKHG1 MYLK3 ALMS1 SSX2IP NHS TANC1 MAP2K2 YTHDF2 WDR62 OTOG	2.51e-08	861	146	18	36931259
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DOCK9 PEG3 PHF6 KLHL32 EPG5 PLEKHG1 SEC24C ACOT11 SGSM2 OGFOD1 SPEN	1.31e-06	407	146	11	12693553
Pubmed	Hypertension-associated C825T polymorphism impairs the function of Gβ3 to target GRK2 ubiquitination.	CUL4A GNG2 GRK2	2.51e-06	7	146	3	27462452
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	LDLRAP1 HEATR1 RIF1 SEC24C RRP9 ZNF638 SMARCE1 ARIH1 MAP2K2 YTHDF2	4.04e-06	370	146	10	22922362
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	CUL4A TRIM73 ROR2 DNAAF9 ALPK1 KLHL32 MYLK3 FGR SPSB3 TRIM74	4.24e-06	372	146	10	22939624
Pubmed	A Non-Canonical Function of Gβ as a Subunit of E3 Ligase in Targeting GRK2 Ubiquitylation.	CUL4A GNG2 GRK2	1.17e-05	11	146	3	25982117
Pubmed	Antioxidants for Healthy Skin: The Emerging Role of Aryl Hydrocarbon Receptors and Nuclear Factor-Erythroid 2-Related Factor-2.	NFE2L2 AHR	1.75e-05	2	146	2	28273792
Pubmed	Thin filament length in the cardiac sarcomere varies with sarcomere length but is independent of titin and nebulin.	NEB RBM20	1.75e-05	2	146	2	27139341
Pubmed	Early Transcriptomic Response to OxLDL in Human Retinal Pigment Epithelial Cells.	NFE2L2 AHR	1.75e-05	2	146	2	33233417
Pubmed	Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling.	AHR LTBP1	1.75e-05	2	146	2	18812170
Pubmed	Introducing the "TCDD-inducible AhR-Nrf2 gene battery".	NFE2L2 AHR	1.75e-05	2	146	2	19474220
Pubmed	Air particulate matter induced oxidative stress and inflammation in cardiovascular disease and atherosclerosis: The role of Nrf2 and AhR-mediated pathways.	NFE2L2 AHR	1.75e-05	2	146	2	28189649
Pubmed	The aryl hydrocarbon receptor interacts with nuclear factor erythroid 2-related factor 2 to mediate induction of NAD(P)H:quinoneoxidoreductase 1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin.	NFE2L2 AHR	1.75e-05	2	146	2	23800876
Pubmed	Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography.	CACNA1C RYR3	1.75e-05	2	146	2	24026422
Pubmed	Perillaldehyde Inhibits AHR Signaling and Activates NRF2 Antioxidant Pathway in Human Keratinocytes.	NFE2L2 AHR	1.75e-05	2	146	2	29643980
Pubmed	Cul4A overexpression associated with Gli1 expression in malignant pleural mesothelioma.	CUL4A GLI1	1.75e-05	2	146	2	26218750
Pubmed	Epitranscriptional regulation of TGF-β pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance.	BAMBI YTHDF2	1.75e-05	2	146	2	38099498
Pubmed	Variants in NEB and RIF1 genes on chr2q23 are associated with skeletal muscle index in Koreans: genome-wide association study.	NEB RIF1	1.75e-05	2	146	2	33674626
Pubmed	HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling.	HEATR1 NFE2L2	1.75e-05	2	146	2	31785531
Pubmed	TGF-β1 promotes cell migration in hepatocellular carcinoma by suppressing reelin expression.	RELN LTBP1	1.75e-05	2	146	2	30447345
Pubmed	Role for RIF1-interacting partner DDX1 in BLM recruitment to DNA double-strand breaks.	DDX1 RIF1	1.75e-05	2	146	2	28544931
Pubmed	Gene expression of detoxifying enzymes in AhR and Nrf2 compound null mutant mouse.	NFE2L2 AHR	1.75e-05	2	146	2	12646173
Pubmed	Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes.	NFE2L2 AHR	1.75e-05	2	146	2	15790560
Pubmed	Indoxyl sulphate-initiated activation of cardiac fibroblasts is modulated by aryl hydrocarbon receptor and nuclear factor-erythroid-2-related factor 2.	NFE2L2 AHR	1.75e-05	2	146	2	38506079
Pubmed	Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway.	NFE2L2 AHR	1.75e-05	2	146	2	30626868
Pubmed	Similar phenotypes caused by mutations in OTOG and OTOGL.	OTOGL OTOG	1.75e-05	2	146	2	24378291
Pubmed	Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice.	F8 MUC2	1.75e-05	2	146	2	19411636
Pubmed	Modulation of cell cycle progression in the spermatocyte cell line [GC-2spd(ts) Cell-Line] by cigarette smoke condensate (CSC) via arylhydrocarbon receptor-nuclear factor erythroid 2-related factor 2 (Ahr-Nrf2) pathway.	NFE2L2 AHR	1.75e-05	2	146	2	24258214
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	USP34 DOCK11 DOCK9 ZNF112 PRAMEF18 EFTUD2 ADAMTS9 NHS SMARCE1	2.45e-05	363	146	9	14691545
Pubmed	The Meckel-Gruber syndrome protein TMEM67 controls basal body positioning and epithelial branching morphogenesis in mice via the non-canonical Wnt pathway.	ROR2 ALMS1 GLI1	3.18e-05	15	146	3	26035863
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	ROCK2 LDLRAP1 WAPL POLE DDX1 EFTUD2 RIF1 SEC24C ZNF638 GEMIN6 MAP2K2	3.75e-05	582	146	11	20467437
Pubmed	The E3-ubiquitin ligase TRIM50 interacts with HDAC6 and p62, and promotes the sequestration and clearance of ubiquitinated proteins into the aggresome.	TRIM73 EEA1 TRIM74	3.90e-05	16	146	3	22792322
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ROCK2 KCTD12 GBF1 ZNF407 ALPK1 ATP8B2 EFTUD2 ALMS1 ADAMTS9 SSX2IP	4.75e-05	493	146	10	15368895
Pubmed	FTO-Nrf2 axis regulates bisphenol F-induced leydig cell toxicity in an m6A-YTHDF2-dependent manner.	NFE2L2 YTHDF2	5.24e-05	3	146	2	36878272
Pubmed	Comparison of Hepatic NRF2 and Aryl Hydrocarbon Receptor Binding in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Treated Mice Demonstrates NRF2-Independent PKM2 Induction.	NFE2L2 AHR	5.24e-05	3	146	2	29752288
Pubmed	Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression.	NFE2L2 AHR	5.24e-05	3	146	2	20395535
Pubmed	A point mutation in the gene for asparagine-linked glycosylation 10B (Alg10b) causes nonsyndromic hearing impairment in mice (Mus musculus).	ALG10B ALG10	5.24e-05	3	146	2	24303013
Pubmed	Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance.	NELFCD NFE2L2	5.24e-05	3	146	2	20298567
Pubmed	Wnt5a/Ror2 promotes Nrf2-mediated tissue protective function of astrocytes after brain injury.	ROR2 NFE2L2	5.24e-05	3	146	2	37904612
Pubmed	The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells.	NFE2L2 AHR	5.24e-05	3	146	2	23583297
Pubmed	Cynaropicrin attenuates UVB-induced oxidative stress via the AhR-Nrf2-Nqo1 pathway.	NFE2L2 AHR	5.24e-05	3	146	2	25680693
Pubmed	Interaction between oxidative stress sensor Nrf2 and xenobiotic-activated aryl hydrocarbon receptor in the regulation of the human phase II detoxifying UDP-glucuronosyltransferase 1A10.	NFE2L2 AHR	5.24e-05	3	146	2	20053997
Pubmed	Roles of the DOCK-D family proteins in a mouse model of neuroinflammation.	DOCK11 DOCK9	5.24e-05	3	146	2	32241915
Pubmed	Gene structure variation in segmental duplication block C of human chromosome 7q 11.23 during primate evolution.	TRIM73 TRIM74	5.24e-05	3	146	2	26196062
Pubmed	Reducing RBM20 activity improves diastolic dysfunction and cardiac atrophy.	NEB RBM20	5.24e-05	3	146	2	27889803
Pubmed	YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis.	MAP2K2 YTHDF2	5.24e-05	3	146	2	35075244
Pubmed	Splice-mediated motif switching regulates disabled-1 phosphorylation and SH2 domain interactions.	RELN DDX1	5.24e-05	3	146	2	22586277
Pubmed	Suppression of Hedgehog signalling promotes pro-tumourigenic integrin expression and function.	ITGB6 GLI1	5.24e-05	3	146	2	24573955
Pubmed	Mutational analysis of Gbetagamma and phospholipid interaction with G protein-coupled receptor kinase 2.	GNG2 GRK2	5.24e-05	3	146	2	10744734
Pubmed	TRIM50 protein regulates vesicular trafficking for acid secretion in gastric parietal cells.	TRIM73 TRIM74	5.24e-05	3	146	2	22872646
Pubmed	Fraction of exhaled nitric oxide values in childhood are associated with 17q11.2-q12 and 17q12-q21 variants.	CACNA1C TSHZ3 NETO1	6.68e-05	19	146	3	24315451
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	KCTD12 USP34 GBF1 KALRN POLE DOCK9 LAMB2 CIT PLEKHG1 GLI1 SGSM2 ZNF408 BAMBI TANC1 SPEN	6.78e-05	1105	146	15	35748872
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	PHF6 PDLIM5 GRK2 ALMS1 SEC24C TAMM41 TANC1 YTHDF2	6.90e-05	322	146	8	39098523
Pubmed	Sp1 is a substrate of Keap1 and regulates the activity of CRL4AWDR23 ubiquitin ligase toward Nrf2.	CUL4A NFE2L2	1.04e-04	4	146	2	33895141
Pubmed	Recruitment of CREB1 and histone deacetylase 2 (HDAC2) to the mouse Ltbp-1 promoter regulates its constitutive expression in a dioxin receptor-dependent manner.	AHR LTBP1	1.04e-04	4	146	2	18508077
Pubmed	Binding of beta gamma subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinase.	GNG2 GRK2	1.04e-04	4	146	2	7972043
Pubmed	Expression of nuclear receptors (AhR, PXR, CAR) and transcription factor (Nrf2) in human parotid gland.	NFE2L2 AHR	1.04e-04	4	146	2	23614276
Pubmed	Teashirt-3, a novel regulator of muscle differentiation, associates with BRG1-associated factor 57 (BAF57) to inhibit myogenin gene expression.	TSHZ3 SMARCE1	1.04e-04	4	146	2	21543328
Pubmed	Latent TGF-β structure and activation.	ITGB6 LTBP1	1.04e-04	4	146	2	21677751
Pubmed	The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines.	ALG10B ALG10	1.04e-04	4	146	2	14525949
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ROCK2 WAPL GBF1 ERG PALB2 EFTUD2 RIF1 SEC24C ZNF638 MAP2K2 SPEN WDR62	1.10e-04	774	146	12	15302935
Pubmed	Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway.	GLI1 SMARCE1	1.74e-04	5	146	2	21076395
Pubmed	Endocytosis of megalin by visceral endoderm cells requires the Dab2 adaptor protein.	LDLRAP1 EEA1	1.74e-04	5	146	2	16263760
Pubmed	Genetic studies of the mouse mutations mahogany and mahoganoid.	ATRN AHR	1.74e-04	5	146	2	9258683
Pubmed	Induced chromosome deletions cause hypersociability and other features of Williams-Beuren syndrome in mice.	TRIM73 TRIM74	1.74e-04	5	146	2	20049703
Pubmed	Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1.	ITGB6 LTBP1	1.74e-04	5	146	2	16260650
Pubmed	Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-null mice.	NFE2L2 AHR	1.74e-04	5	146	2	22496397
Pubmed	Nrf2 Transcriptional Activity Governs Intestine Development.	NFE2L2 MUC2	1.74e-04	5	146	2	35682851
Pubmed	Association of the proto-oncogene product dbl with G protein betagamma subunits.	KALRN GNG2	1.74e-04	5	146	2	10518015
Pubmed	Williams-Beuren syndrome TRIM50 encodes an E3 ubiquitin ligase.	TRIM73 TRIM74	1.74e-04	5	146	2	18398435
Pubmed	AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer.	NFE2L2 AHR	1.74e-04	5	146	2	30733286
Pubmed	Zizimin2: a novel, DOCK180-related Cdc42 guanine nucleotide exchange factor expressed predominantly in lymphocytes.	DOCK11 DOCK9	1.74e-04	5	146	2	15710388
Pubmed	Normal sorting but defective endocytosis of the low density lipoprotein receptor in mice with autosomal recessive hypercholesterolemia.	LDLRAP1 EEA1	1.74e-04	5	146	2	12746448
Pubmed	NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis.	NFE2L2 AHR	1.74e-04	5	146	2	17709388
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CUL4A CACNA1C ATRN DHRS3 ROR2 PHF6 MICU1 EFNA5 BRI3BP NETO1 SGSM2 ZNF638 TANC1 XYLB ARIH1 MAP2K2 ADGRD1	1.79e-04	1489	146	17	28611215
Pubmed	Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.	GBF1 HMCN1 NFE2L2 TANC1 ARIH1	2.13e-04	128	146	5	25332235
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	IFT140 GBF1 CENPL RIPK4 ALPK1 PRAMEF18 CIT ATP8B2 PLEKHG1 ZNF408 OGFOD1 LTBP1 CFAP61 MAP2K2 ADGRD1	2.42e-04	1242	146	15	30973865
Pubmed	A genome-wide association study identifies susceptibility loci for Wilms tumor.	DDX1 NHS	2.60e-04	6	146	2	22544364
Pubmed	TRIM50 regulates Beclin 1 proautophagic activity.	TRIM73 TRIM74	2.60e-04	6	146	2	29604308
Pubmed	Direct interaction of the Rab3 effector RIM with Ca2+ channels, SNAP-25, and synaptotagmin.	CACNA1C RAPGEF4	2.60e-04	6	146	2	11438518
Pubmed	Analysis of recombinant inbred lines derived from "autoimmune" (NZB) and "high leukemia" (C58) strains: independent multigenic systems control B cell hyperactivity, retrovirus expression, and autoimmunity.	GPT AHR	2.60e-04	6	146	2	6980942
Pubmed	TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization.	TRIM73 TRIM74	2.60e-04	6	146	2	36178239
Pubmed	A family of cellular proteins related to snake venom disintegrins.	ADAM18 ADAM28	2.60e-04	6	146	2	8146185
Pubmed	The RhoGEF DOCK10 is essential for dendritic spine morphogenesis.	DOCK11 DOCK9	2.60e-04	6	146	2	25851601
Pubmed	Multiple origins of Cajal-Retzius cells at the borders of the developing pallium.	RELN DDX1	2.60e-04	6	146	2	16041369
Pubmed	Alpha-kinases: a new class of protein kinases with a novel catalytic domain.	TRPM7 ALPK1	2.60e-04	6	146	2	10021370
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CACNA1C WAPL DOCK11 DOCK9 RAPGEF4 NEB RYR3 HP ZNF408	2.65e-04	497	146	9	36774506
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	OR8H2 CUL4A USP34 IFT140 WAPL GPT ALMS1 GCAT SSX2IP AHR SMARCE1 TANC1 XYLB WDR62	2.69e-04	1116	146	14	31753913
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	CUL4A GBF1 KALRN UGGT1 GPT TNS2 DDX1	3.13e-04	304	146	7	32235678
Pubmed	WDR23 regulates NRF2 independently of KEAP1.	CUL4A NFE2L2	3.63e-04	7	146	2	28453520
Pubmed	MRCKα is activated by caspase cleavage to assemble an apical actin ring for epithelial cell extrusion.	ROCK2 CIT	3.63e-04	7	146	2	29162624
Pubmed	Identification of genes differentially expressed in mouse fetuses from streptozotocin-induced diabetic pregnancy by cDNA subtraction.	DDX1 EFNA5	3.63e-04	7	146	2	18323671
Pubmed	Reciprocal interaction between mesenchymal stem cells and transit amplifying cells regulates tissue homeostasis.	ROR2 GLI1	3.63e-04	7	146	2	33480845
Pubmed	Allele-specific binding of ZFP57 in the epigenetic regulation of imprinted and non-imprinted monoallelic expression.	TRIM73 TRIM74	3.63e-04	7	146	2	26025256
Pubmed	Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication.	ROCK2 EEA1	3.63e-04	7	146	2	19376974
Pubmed	Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.	BAMBI LTBP1	3.63e-04	7	146	2	19998449
Pubmed	PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function.	PALB2 NFE2L2	3.63e-04	7	146	2	22331464
Pubmed	Longitudinal cell formation in the entire human small intestine is correlated with the localization of Hath1 and Klf4.	LCT MUC2	3.63e-04	7	146	2	21125297
Pubmed	Baicalein modulates Nrf2/Keap1 system in both Keap1-dependent and Keap1-independent mechanisms.	NFE2L2 MAP2K2	3.63e-04	7	146	2	24704364
Interaction	FBXO3 interactions	TNS2 CIT EFTUD2 RECQL4 PLCD1 ARIH1	1.08e-05	72	140	6	int:FBXO3
Interaction	FHL2 interactions	CACNA1C LDLRAP1 WAPL TRIM73 ITGB6 EFTUD2 ALMS1 ZNF408 AHR ZNF638 SPEN WDR62	2.13e-05	396	140	12	int:FHL2
Interaction	YWHAH interactions	GBF1 TRPM7 DOCK11 NELFCD DOCK9 ROR2 TNS2 RIPK4 DDX1 EFTUD2 PLEKHG1 ALMS1 RECQL4 SSX2IP ZNF638 NHS TANC1 MAP2K2 YTHDF2 WDR62 OTOG	2.43e-05	1102	140	21	int:YWHAH
Interaction	EFEMP1 interactions	KCTD7 CACNA1C UGGT1 LAMB2 CIT ZNF408 LTBP1	2.44e-05	123	140	7	int:EFEMP1
Interaction	CNOT9 interactions	GBF1 RBM20 EFTUD2 PLEKHG1 ZC3H7A ALMS1 SSX2IP YTHDF2 TRIM74	3.49e-05	231	140	9	int:CNOT9
Cytoband	3p22-p21.3	PLCD1 XYLB	6.00e-05	4	146	2	3p22-p21.3
GeneFamily	Alpha-1,2-glucosyltransferases	ALG10B ALG10	2.79e-05	2	96	2	448
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	KCTD7 ROCK2 KCTD12 WAPL PDPR ERG B3GNT5 TRPM7 CENPL POLE MRGPRE ROR2 PHF6 CIT ZC3H7A CLIP3 RIF1 ALMS1 NFE2L2 ZNF638 NHS BAMBI SMARCE1 XYLB CFAP61	6.16e-07	1252	140	25	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000	KCTD12 TSHZ3 WAPL B3GNT5 DOCK11 ROR2 PEG3 RBM48 TBC1D8B CYP39A1 CLIP3 EFNA5 TRAM1L1 HMCN1 ACOT11 SBSPON GLI1 TANC1 KLHL4	1.13e-06	791	140	19	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500	KCTD12 TSHZ3 B3GNT5 DOCK11 ROR2 PEG3 CYP39A1 EFNA5 HMCN1 ACOT11 SBSPON GLI1 KLHL4	1.83e-06	388	140	13	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	ROCK2 CACNA1C TMEM141 B3GNT5 TRPM7 POLE MRGPRE ROR2 PEG3 PHF6 HEATR1 CIT PALB2 CLIP3 RIF1 ALMS1 TAMM41 NHS BAMBI SMARCE1 XYLB	6.41e-05	1241	140	21	facebase_RNAseq_e10.5_MandArch_2500_K1
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RELN ERG KALRN RAPGEF4 PLEKHG1 EFNA5 HMCN1 ADAMTS9 TANC1 KLHL4	7.65e-10	190	146	10	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	IPF-Endothelial-Lymphatic\|World / Disease state, Lineage and Cell class	RELN ERG KALRN DOCK9 RAPGEF4 PLEKHG1 EFNA5 ADAMTS9 TANC1 KLHL4	7.65e-10	190	146	10	ac029e73da5995221c9b9af551d85e4b835e21d6
ToppCell	IPF-Endothelial-Lymphatic\|IPF / Disease state, Lineage and Cell class	RELN ERG KALRN DOCK9 RAPGEF4 PLEKHG1 EFNA5 ADAMTS9 TANC1 KLHL4	8.47e-10	192	146	10	2496edd8f3a41146d418879de9ee2ccc7857431f
ToppCell	nucseq-Endothelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RELN ERG KALRN DOCK9 RAPGEF4 F8 PLEKHG1 ADAMTS9 TANC1 KLHL4	1.09e-09	197	146	10	ebf9be068eaa658493fa7884fd19f34642922acb
ToppCell	356C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	RELN ERG KALRN CYP39A1 F8 PLEKHG1 ADAMTS9 SBSPON KLHL4	4.27e-09	166	146	9	5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f
ToppCell	356C-Endothelial_cells-Endothelial-F_(Lymphatics)\|356C / Donor, Lineage, Cell class and subclass (all cells)	RELN ERG KALRN CYP39A1 F8 PLEKHG1 ADAMTS9 SBSPON KLHL4	4.27e-09	166	146	9	6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122\|Adult / Lineage, Cell type, age group and donor	RELN ERG KALRN F8 RBM20 PLEKHG1 EFNA5 ADAMTS9 KLHL4	6.13e-09	173	146	9	dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	RELN ERG KALRN DOCK9 RAPGEF4 PLEKHG1 EFNA5 ADAMTS9 KLHL4	7.12e-09	176	146	9	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	RELN ERG KALRN DOCK9 RAPGEF4 PLEKHG1 EFNA5 ADAMTS9 KLHL4	7.12e-09	176	146	9	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231\|Adult / Lineage, Cell type, age group and donor	RELN ERG KALRN RAPGEF4 F8 PLEKHG1 EFNA5 ADAMTS9 KLHL4	7.86e-09	178	146	9	c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCell	COVID-19-Neuronal_cells-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	RELN ERG KALRN DOCK9 F8 PLEKHG1 EFNA5 ADAMTS9 KLHL4	1.10e-08	185	146	9	4a095829992b39856a73bdfac03ee68b9aa0d3b8
ToppCell	COVID-19-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	RELN ERG KALRN DOCK9 F8 PLEKHG1 EFNA5 ADAMTS9 KLHL4	1.10e-08	185	146	9	36ce23893915f5c380cca39b2c33a516edf31c3a
ToppCell	Endothelial-endothelial_cell_of_lymph_vessel\|World / Lineage, Cell type, age group and donor	RELN ERG KALRN RAPGEF4 F8 PLEKHG1 EFNA5 ADAMTS9 KLHL4	1.27e-08	188	146	9	80910dcbb51990f2baed240f319456c0d3fa2065
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RELN ERG KALRN DOCK9 RAPGEF4 F8 EFNA5 ADAMTS9 KLHL4	1.32e-08	189	146	9	55a1776a4ce049959b3f13a43744c7314bc1f00a
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	RELN ERG KALRN RAPGEF4 F8 PLEKHG1 EFNA5 ADAMTS9 KLHL4	1.39e-08	190	146	9	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	Control-Endothelial-Lymphatic\|World / Disease state, Lineage and Cell class	RELN ERG KALRN RAPGEF4 PLEKHG1 EFNA5 ADAMTS9 TANC1 KLHL4	1.52e-08	192	146	9	f95fb188aa642f3d0618242a770e7c4b70544adb
ToppCell	COPD-Endothelial-Lymphatic\|World / Disease state, Lineage and Cell class	RELN ERG KALRN DOCK9 PLEKHG1 EFNA5 ADAMTS9 TANC1 KLHL4	1.59e-08	193	146	9	25bdc557055b5bce6a21f8696b48e991c696b979
ToppCell	COPD-Endothelial-Lymphatic\|COPD / Disease state, Lineage and Cell class	RELN ERG KALRN DOCK9 PLEKHG1 EFNA5 ADAMTS9 TANC1 KLHL4	1.59e-08	193	146	9	18bcf08068a236c4575c7a07181ac893dfdcbeeb
ToppCell	Control-Endothelial-Lymphatic\|Control / Disease state, Lineage and Cell class	RELN ERG KALRN RAPGEF4 PLEKHG1 EFNA5 ADAMTS9 TANC1 KLHL4	1.59e-08	193	146	9	64d19be73e5432d491436a01da5de5c926b615a9
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RELN ERG KALRN DOCK9 RAPGEF4 F8 PLEKHG1 TANC1 KLHL4	1.74e-08	195	146	9	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C KALRN RBM20 PDLIM5 ADAMTS9 SBSPON GADL1 NHS LTBP1	2.16e-08	200	146	9	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_lymphatic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	RELN ERG F8 PLEKHG1 EFNA5 ADAMTS9 HP SBSPON KLHL4	2.16e-08	200	146	9	b515b2ab0c3f5928dd67f2f227fc932451c272bb
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	RELN ERG F8 PLEKHG1 EFNA5 ADAMTS9 HP SBSPON KLHL4	2.16e-08	200	146	9	35f6c7f2469d12748c27f2a5d4a161ef839b4a07
ToppCell	COVID-19-Heart-EC_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C ERG KALRN DOCK9 RAPGEF4 F8 PLEKHG1 ADAMTS9	1.68e-07	183	146	8	ff95382cfed592190d0636d2b750328471f82e0d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN KALRN NEB RYR3 HMCN1 OTOGL MYO16 OTOG	1.75e-07	184	146	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN KALRN NEB RYR3 HMCN1 OTOGL MYO16 OTOG	1.75e-07	184	146	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN KALRN NEB RYR3 HMCN1 OTOGL MYO16 OTOG	1.75e-07	184	146	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RELN ERG KALRN DOCK9 F8 EFNA5 SBSPON KLHL4	1.82e-07	185	146	8	f9f48251bc33eb6bf2cff580d1a3207d21450aa0
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CACNA1C ERG DHRS3 RYR3 SSX2IP NHS LTBP1 ADGRD1	1.90e-07	186	146	8	4d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175\|Adult / Lineage, Cell type, age group and donor	RELN ERG KALRN RAPGEF4 PLEKHG1 EFNA5 ADAMTS9 KLHL4	1.98e-07	187	146	8	1e52d3d9d664c813d859b5b75e4c07b218818f95
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RELN ERG KALRN RAPGEF4 F8 PLEKHG1 EFNA5 KLHL4	2.06e-07	188	146	8	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RELN ERG KALRN RAPGEF4 F8 EFNA5 HMCN1 KLHL4	2.06e-07	188	146	8	2db80767903703e7e0a1a37c598f7877a909ee94
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RELN ERG KALRN F8 PLEKHG1 EFNA5 ADAMTS9 KLHL4	2.06e-07	188	146	8	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	CACNA1C TRPM7 RBM20 PDLIM5 EFNA5 MYLK3 ACOT11 CFAP61	2.15e-07	189	146	8	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C ROR2 GFRA1 CLIP3 EFNA5 GLI1 LONRF2 ADGRD1	2.15e-07	189	146	8	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	CACNA1C TRPM7 RBM20 PDLIM5 EFNA5 MYLK3 ACOT11 CFAP61	2.24e-07	190	146	8	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	GBF1 TRPM7 TRIM73 HEATR1 ALG10 XYLB POLQ SPEN	2.33e-07	191	146	8	9454f642c3621370fa23640b631301346b300950
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C ROR2 GFRA1 CLIP3 EFNA5 GLI1 LONRF2 ADGRD1	2.33e-07	191	146	8	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	LAM-Endothelial-LymEndo\|LAM / Condition, Lineage and Cell class	RELN ERG KALRN F8 PLEKHG1 EFNA5 ADAMTS9 KLHL4	2.52e-07	193	146	8	68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9
ToppCell	COVID-19-Endothelial_cells-Inflamed_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ERG KALRN DOCK9 RAPGEF4 PLEKHG1 ADAMTS9 TANC1 IL1RL1	2.52e-07	193	146	8	979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCell	nucseq-Endothelial-Endothelial_Lymphatic-LEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RELN ERG KALRN F8 PLEKHG1 EFNA5 ADAMTS9 KLHL4	2.62e-07	194	146	8	f772a9f9ef8635aeaeb8b022dbb94e9672b36ead
ToppCell	nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RELN ERG KALRN F8 PLEKHG1 EFNA5 ADAMTS9 KLHL4	2.62e-07	194	146	8	3b73f2d305a7566f7ab567e5f18c82cd3d80e32c
ToppCell	nucseq-Endothelial-Endothelial_Lymphatic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RELN ERG KALRN F8 PLEKHG1 EFNA5 ADAMTS9 KLHL4	2.62e-07	194	146	8	5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 DHRS3 KALRN ADARB2 PDLIM5 LTBP1 TANC1 ADGRD1	2.73e-07	195	146	8	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 DHRS3 KALRN ADARB2 PDLIM5 LTBP1 TANC1 ADGRD1	2.73e-07	195	146	8	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KCTD12 RELN ERG KALRN F8 PLEKHG1 ADAMTS9 KLHL4	2.83e-07	196	146	8	09a7edf4a7defb7fe70d9777dd9500ee8421ff31
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KCTD12 RELN ERG KALRN F8 PLEKHG1 ADAMTS9 KLHL4	2.83e-07	196	146	8	e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 ERG KALRN ROR2 PDLIM5 HMCN1 LTBP1 ADGRD1	2.83e-07	196	146	8	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 ERG KALRN ROR2 PDLIM5 HMCN1 LTBP1 ADGRD1	2.83e-07	196	146	8	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RELN ERG KALRN RAPGEF4 F8 PLEKHG1 EFNA5 KLHL4	3.06e-07	198	146	8	9ab0db78394e730f6866b2db80047149024ad5f6
ToppCell	5'-Adult-Appendix-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KCTD12 RELN ERG DOCK9 TNS2 F8 PLEKHG1 ADAMTS9	3.06e-07	198	146	8	90e85fe7a0ab376a41666dfff6c0e95b7f1c9475
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RELN ERG KALRN RAPGEF4 F8 PLEKHG1 EFNA5 KLHL4	3.06e-07	198	146	8	e47d0e2c6353315c85d7007742bb16b0f05795ed
ToppCell	5'-Adult-SmallIntestine-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KCTD12 RELN ERG DOCK9 TNS2 F8 PLEKHG1 ADAMTS9	3.30e-07	200	146	8	2554b77edfe3d378296b0b25625caacbfb1c0e76
ToppCell	Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TRIM73 PEG3 ZNF407 ALPK1 ZNF181 EFNA5 NHS	4.11e-07	140	146	7	0e1e9281de87df178ac41ed6b697b4fa09be2749
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D122\|Adult / Lineage, Cell type, age group and donor	CACNA1C ROR2 GFRA1 OTOGL GLI1 LTBP1 POLQ	9.29e-07	158	146	7	410fa08c9d880d27e80ec939fa5ba5a41dcb31ab
ToppCell	Adult-Mesenchymal-myofibroblast_cell\|Adult / Lineage, Cell type, age group and donor	CACNA1C ROR2 GFRA1 HMCN1 GLI1 LTBP1 POLQ	1.35e-06	167	146	7	d584a8548a5317bd9686b3be8246ae6ed568796b
ToppCell	Bronchial_Biopsy-Immune-Mast_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	ERG WWC3 KALRN TBC1D8B RYR3 MYLK3 IL1RL1	1.40e-06	168	146	7	45ccc0cb42d21f4853190e8e9ed9a54aefefe738
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9\|TCGA-Bladder / Sample_Type by Project: Shred V9	ATRN DHRS3 RIPK4 TBC1D8B NFE2L2 SPEN PRODH	1.58e-06	171	146	7	adbcfa4bf6bc1c604535a24435924cdb091e2dd7
ToppCell	Control-Endothelial_cells-Systemic_venous_endothelial_cells\|Control / group, cell type (main and fine annotations)	ERG KALRN DOCK9 RAPGEF4 PLEKHG1 ADAMTS9 KLHL4	1.64e-06	172	146	7	c55dce1ed3ed7312394b4e050e1de852a994e130
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	CACNA1C KALRN RBM20 RYR3 SBSPON GADL1 LTBP1	1.70e-06	173	146	7	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	CV-Severe-7\|CV / Virus stimulation, Condition and Cluster	KCTD12 KALRN TRIM73 UGGT1 ZNF407 HEATR1 ALG10	1.91e-06	176	146	7	3de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell	COVID-19-Heart-Lymph_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RELN ERG KALRN DOCK9 PLEKHG1 EFNA5 KLHL4	1.98e-06	177	146	7	326fde0734ef0d7272693966d346ca479b9d8147
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RELN ERG KALRN F8 PLEKHG1 EFNA5 KLHL4	2.06e-06	178	146	7	ad3de3e03a401dac64431a541899445262246347
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	ERG KALRN DOCK9 RAPGEF4 F8 PLEKHG1 ADAMTS9	2.30e-06	181	146	7	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RELN ERG KALRN LAMB2 F8 EFNA5 KLHL4	2.47e-06	183	146	7	4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCell	5'-Adult-Appendix-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RELN DOCK9 LAMB2 F8 PLEKHG1 ADAMTS9 KLHL4	2.56e-06	184	146	7	453295362888c9a59d0e73c7a5b15914c50ff591
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ERG DOCK9 RAPGEF4 F8 PLEKHG1 ADAMTS9 LTBP1	2.56e-06	184	146	7	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C RBM20 PDLIM5 EFNA5 MYLK3 LTBP1 CFAP61	2.66e-06	185	146	7	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	COPD-Endothelial-VE_Peribronchial\|World / Disease state, Lineage and Cell class	ERG KALRN DOCK9 RAPGEF4 PLEKHG1 ADAMTS9 TANC1	2.66e-06	185	146	7	4abe04198ab5047c211f8d09cdb9650fa52a3cd6
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	GBF1 TRPM7 TRIM73 HEATR1 XYLB POLQ SPEN	2.66e-06	185	146	7	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PDPR POLE PEG3 RIPK4 KLHL32 SGSM2 PRODH	2.66e-06	185	146	7	636505a3d96f75d951ab42bcf8af6ae07abc732d
ToppCell	COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ERG KALRN DOCK9 RAPGEF4 F8 PLEKHG1 ADAMTS9	2.66e-06	185	146	7	f5e14181f45c37d13ee9e017a4c8bc248c353676
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KCTD12 CACNA1C ERG ADARB2 NHS LTBP1 ADGRD1	2.66e-06	185	146	7	1ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCell	Control-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	ERG KALRN DOCK9 RAPGEF4 PLEKHG1 TANC1 IL1RL1	2.66e-06	185	146	7	a28187c2fd23564314b35759479ff2ca21f61485
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	GBF1 TRPM7 TRIM73 HEATR1 XYLB POLQ SPEN	2.75e-06	186	146	7	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LDLRAP1 KALRN DOCK9 TNS2 ADAMTS9 TANC1 KLHL4	2.75e-06	186	146	7	a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C KALRN TNS2 ADARB2 ADAMTS9 OTOGL ADGRD1	2.85e-06	187	146	7	86250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	CACNA1C KALRN ROR2 RBM20 PDLIM5 NHS LTBP1	2.85e-06	187	146	7	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ERG KALRN DOCK9 RAPGEF4 F8 PLEKHG1 ADAMTS9	2.85e-06	187	146	7	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	Control-Endothelial-VE_Capillary_A\|Control / Disease state, Lineage and Cell class	ERG KALRN DOCK9 RAPGEF4 PLEKHG1 TANC1 IL1RL1	2.85e-06	187	146	7	54d7588172ac145ff5045ad9771636729ca3f0ca
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	CACNA1C NEB RBM20 PDLIM5 MYLK3 LTBP1 TANC1	2.96e-06	188	146	7	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	COVID-19-lung-Artery_EC\|lung / Disease (COVID-19 only), tissue and cell type	ERG DOCK9 RAPGEF4 F8 PLEKHG1 ADAMTS9 LTBP1	2.96e-06	188	146	7	eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCell	Control-Endothelial-VE_Peribronchial\|World / Disease state, Lineage and Cell class	ERG KALRN DOCK9 RAPGEF4 PLEKHG1 ADAMTS9 TANC1	3.06e-06	189	146	7	c76d8af2e0aa4a83ee0c3439c894566fbf117dd3
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IFT140 ERG KALRN DOCK9 PLEKHG1 TANC1 IL1RL1	3.06e-06	189	146	7	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ERG KALRN DOCK9 RAPGEF4 F8 PLEKHG1 ADAMTS9	3.06e-06	189	146	7	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	ERG DOCK9 RAPGEF4 F8 PLEKHG1 HMCN1 ADAMTS9	3.06e-06	189	146	7	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	ERG DOCK9 RAPGEF4 F8 PLEKHG1 HMCN1 ADAMTS9	3.06e-06	189	146	7	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ROCK2 ERG DOCK9 F8 PLEKHG1 ADAMTS9 NHS	3.17e-06	190	146	7	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C ERG RBM20 PDLIM5 HMCN1 ADAMTS9 NHS	3.17e-06	190	146	7	d6b3a92119b210974a32af3fe9875d60eb02761e
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ERG KALRN DOCK9 RAPGEF4 F8 PLEKHG1 ADAMTS9	3.17e-06	190	146	7	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	CACNA1C TRPM7 RBM20 PDLIM5 EFNA5 MYLK3 ACOT11	3.17e-06	190	146	7	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RELN ERG DHRS3 KALRN GNG2 RAPGEF4 PLEKHG1	3.28e-06	191	146	7	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	CACNA1C TRPM7 RBM20 PDLIM5 EFNA5 MYLK3 ACOT11	3.28e-06	191	146	7	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C ROR2 PEG3 GFRA1 EFNA5 MYO16 ADGRD1	3.28e-06	191	146	7	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	Control-Endothelial-VE_Capillary_B\|Control / Disease state, Lineage and Cell class	ERG DOCK9 RAPGEF4 PLEKHG1 ADAMTS9 TANC1 IL1RL1	3.28e-06	191	146	7	322237793a1278bafb14e63cab688b353e352dcc
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	CACNA1C KALRN RBM20 HMCN1 ADAMTS9 NHS LTBP1	3.28e-06	191	146	7	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	ERG KALRN DOCK9 F8 PLEKHG1 ADAMTS9 NETO1	3.28e-06	191	146	7	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C ERG DOCK9 RAPGEF4 F8 PLEKHG1 ADAMTS9	3.40e-06	192	146	7	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG KALRN DOCK9 RAPGEF4 PDLIM5 HMCN1 ADAMTS9	3.40e-06	192	146	7	52acaecd3703166f5ce3b328aff7c82bd142fee4
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	TRPM7 RBM20 PDLIM5 EFNA5 MYLK3 ACOT11 TANC1	3.40e-06	192	146	7	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
Disease	asparaginase-induced acute pancreatitis	NEB PDLIM5 SBSPON	8.60e-06	9	140	3	EFO_1001507
Disease	Anemia, Sickle Cell	CACNA1C HP NFE2L2	1.22e-05	10	140	3	C0002895
Disease	Pierson syndrome (implicated_via_orthology)	LAMB2 TNS2	2.24e-05	2	140	2	DOID:0060852 (implicated_via_orthology)
Disease	liver cirrhosis (is_marker_for)	RELN GPT ITGB6 GRK2 HP	4.55e-05	82	140	5	DOID:5082 (is_marker_for)
Disease	Long Qt Syndrome 2	ALG10B ALG10	6.68e-05	3	140	2	C3150943
Disease	Hepatitis C, Chronic	ITGB6 HP	6.68e-05	3	140	2	C0524910
Disease	hemolytic-uremic syndrome (is_marker_for)	HP IL1RL1	2.21e-04	5	140	2	DOID:12554 (is_marker_for)
Disease	nonsyndromic deafness (implicated_via_orthology)	ALG10B ALG10	3.31e-04	6	140	2	DOID:0050563 (implicated_via_orthology)
Disease	Stage IV Skin Melanoma	ADAM18 ADAM28	4.62e-04	7	140	2	C1321872
Disease	glucagon-like peptide-1 measurement, glucose tolerance test	GPT RAPGEF4	6.14e-04	8	140	2	EFO_0004307, EFO_0008465
Disease	Cardiomegaly	ROCK2 GRK2 AHR BAMBI	6.37e-04	82	140	4	C0018800
Disease	Cardiac Hypertrophy	ROCK2 GRK2 AHR BAMBI	6.37e-04	82	140	4	C1383860
Disease	osteoarthritis	RELN SLC36A4 LCT ADARB2 GRK2 LTBP1	6.88e-04	222	140	6	MONDO_0005178
Disease	liver cancer (is_marker_for)	GPT ADAM28	7.87e-04	9	140	2	DOID:3571 (is_marker_for)
Disease	response to radiation	SLC36A4 ADARB2 EPG5 TANC1	8.31e-04	88	140	4	GO_0009314
Disease	Nephroblastoma	DDX1 NHS	9.81e-04	10	140	2	Orphanet_654
Disease	colitis (biomarker_via_orthology)	LCT HP MUC2	1.05e-03	42	140	3	DOID:0060180 (biomarker_via_orthology)
Disease	Autoimmune Diseases	F8 ITGB6 HP	1.05e-03	42	140	3	C0004364
Disease	Major Depressive Disorder	CACNA1C RELN KALRN PDLIM5 SEC24C HP	1.10e-03	243	140	6	C1269683
Disease	chronic obstructive pulmonary disease (is_marker_for)	HP NFE2L2 BAMBI IL1RL1	1.20e-03	97	140	4	DOID:3083 (is_marker_for)
Disease	Liver Cirrhosis	TRPM7 NFE2L2 AHR BAMBI	1.49e-03	103	140	4	C0023890
Disease	Unipolar Depression	CACNA1C RELN KALRN PDLIM5 SEC24C HP	1.52e-03	259	140	6	C0041696
Disease	Fibrosis, Liver	TRPM7 NFE2L2 AHR BAMBI	1.60e-03	105	140	4	C0239946
Disease	ocular hypertension, response to triamcinolone acetonide	OTOGL CFAP61 SPSB3	1.64e-03	49	140	3	EFO_0006954, EFO_1001069
Disease	Coffin-Siris syndrome	PHF6 SMARCE1	1.68e-03	13	140	2	C0265338
Disease	N-acetylglutamine measurement	ALMS1 RRP9	1.68e-03	13	140	2	EFO_0800017
Disease	Congestive heart failure	ROCK2 GRK2 NFE2L2 BAMBI	1.90e-03	110	140	4	C0018802
Disease	Heart failure	ROCK2 GRK2 NFE2L2 BAMBI	1.90e-03	110	140	4	C0018801
Disease	Left-Sided Heart Failure	ROCK2 GRK2 NFE2L2 BAMBI	1.90e-03	110	140	4	C0023212
Disease	Heart Failure, Right-Sided	ROCK2 GRK2 NFE2L2 BAMBI	1.90e-03	110	140	4	C0235527
Disease	Heart Decompensation	ROCK2 GRK2 NFE2L2 BAMBI	1.90e-03	110	140	4	C1961112
Disease	Myocardial Failure	ROCK2 GRK2 NFE2L2 BAMBI	1.90e-03	110	140	4	C1959583
Disease	Tobacco Dependence	PLEKHG1 AHR	1.96e-03	14	140	2	C0040332
Disease	Nicotine Dependence	PLEKHG1 AHR	1.96e-03	14	140	2	C0028043
Disease	Nicotine Use Disorder	PLEKHG1 AHR	1.96e-03	14	140	2	C0376384
Disease	Bipolar Disorder	KCTD12 CACNA1C RELN DOCK9 PALB2 PDLIM5 SEC24C PRODH	2.05e-03	477	140	8	C0005586
Disease	hair morphology measurement	ADARB2 CPO SMARCE1	2.17e-03	54	140	3	EFO_0007821
Disease	Hepatomegaly	NFE2L2 SBSPON AHR	2.17e-03	54	140	3	C0019209
Disease	caffeine measurement	LAMB2 AHR	2.25e-03	15	140	2	EFO_0021177
Disease	glycerate measurement	RYR3 HMCN1	2.25e-03	15	140	2	EFO_0021029
Disease	ureidopropionic acid measurement	ADARB2 OTOG	2.57e-03	16	140	2	EFO_0010542
Disease	phosphatidylcholine 38:6 measurement	CPO LTBP1	2.57e-03	16	140	2	EFO_0010388
Disease	pre-malignant neoplasm (biomarker_via_orthology)	GLI1 MUC2	2.90e-03	17	140	2	DOID:0060071 (biomarker_via_orthology)
Disease	Antibody Deficiency Syndrome	CACNA1C EPG5	2.90e-03	17	140	2	C0003257
Disease	1-Methylhistidine measurement	ALMS1 OTOGL	2.90e-03	17	140	2	EFO_0021543
Disease	acute kidney failure (biomarker_via_orthology)	GPT HP NFE2L2	3.08e-03	61	140	3	DOID:3021 (biomarker_via_orthology)
Disease	household income	GBF1 KALRN TRPM7 EFNA5 SGSM2 LONRF2	3.37e-03	304	140	6	EFO_0009695
Disease	cognitive function measurement	CACNA1C USP34 GBF1 KALRN KLHL32 RYR3 PLEKHG1 EFNA5 ALMS1 ZNF638 LTBP1 EEA1 LONRF2 MUC2 PRDM14	3.41e-03	1434	140	15	EFO_0008354
Disease	Cardiomyopathies	RBM20 EPG5 GRK2 MAP2K2	3.48e-03	130	140	4	C0878544
Disease	blood metabolite measurement	ALMS1 PRODH	3.63e-03	19	140	2	EFO_0005664
Disease	Liver Cirrhosis, Experimental	ATRN DHRS3 GPT ITGB6 GFRA1 GCAT NFE2L2 LTBP1 FGR PRODH	3.93e-03	774	140	10	C0023893
Disease	sphingomyelin 22:0 measurement	HEATR1 GADL1	4.02e-03	20	140	2	EFO_0010395
Disease	QT interval	CUL4A GBF1 B3GNT5 TRPM7 LAMB2 PDLIM5 TRIM74 RSKR	4.07e-03	534	140	8	EFO_0004682
Disease	Vertigo	GFRA1 OTOGL SBSPON OTOG	4.41e-03	139	140	4	HP_0002321
Disease	Left Ventricle Remodeling	ROCK2 NFE2L2	4.42e-03	21	140	2	C0600520
Disease	Ventricular Remodeling	ROCK2 NFE2L2	4.42e-03	21	140	2	C0600519

Protein segments in the cluster

Peptide	Gene	Start	Entry
HSKCTELDYPMGSFE	AHR	711	P35869
LASFHSTSKGYMGEC	GPT	306	P24298
HMAETTEACITAYFK	EPG5	2321	Q9HCE0
STKDLESMGYHFCDS	AGBL3	551	Q8NEM8
HCFNDKDYALMSLCS	CFAP61	721	Q8NHU2
FSMSCVYILHKYEGE	BRI3BP	166	Q8WY22
GMFHDDYSCKCPSTI	ADAM28	346	Q9UKQ2
AMYFTAAIGKHALLS	ADGRD1	241	Q6QNK2
KLGSDMDHLQSCYSK	SSX2IP	126	Q9Y2D8
ASGRKIFSNCSMHDY	ADAM18	351	Q9Y3Q7
CAYGTPHLAKTEMTA	ERG	21	P11308
STMCFHYRDKHNAKG	GPR34	201	Q9UPC5
NMKFNLAHDCGYSIS	ALMS1	2516	Q8TCU4
AFKHSMEVGVCVEAY	ACOT11	291	Q8WXI4
MCLYGNHKTSAFLGF	ALG10B	166	Q5I7T1
KDDILCFLTMHSYGQ	CPO	226	Q8IVL8
EYATHFTEAFCRDKM	CIT	1416	O14578
HAASQLCKEAMGKLY	ALPK1	376	Q96QP1
CMSYAFHTPDKLSFI	GRK2	256	P25098
MVFNKCSINGHSYGD	ATP8B2	421	P98198
AFYSDGEISICMEHM	MAP2K2	136	P36507
CGLFYTSEETAKMSH	RBM20	1166	Q5T481
DFHSEMSGFCKAALN	RBM48	171	Q5RL73
LVMKHSYSQDAADAC	NETO1	476	Q8TDF5
DTPSMYCEAKLGAHT	ADARB2	691	Q9NS39
ISYCTADKMHDKVFA	LDLRAP1	116	Q5SW96
SYFTGLECGHKFCMQ	ARIH1	196	Q9Y4X5
MSCAKYEFTDALLCH	OGFOD1	141	Q8N543
FLGTAECYLLSSMAH	OR8H2	106	Q8N162
CYEDTMLAAMFSGRH	KCTD7	71	Q96MP8
EHTFCAGMSKYQEDT	HP	336	P00738
EFAKMVCHGEHTYLF	NELFCD	226	Q8IXH7
YIVTEFMCHGSLLDF	FGR	331	P09769
LHMACASGYKEVVSL	MYO16	226	Q9Y6X6
HGAKCFSSDFMAYDI	ATRN	581	O75882
FTMHDTIGCYLDIDK	DDX1	186	Q92499
LSFYHMAGASLDKVT	MICU1	381	Q9BPX6
GLCHLDSKNEYSMST	ITGB6	291	P18564
DCFDGYHLDTAKMTC	LTBP1	1646	Q14766
VMYSAKAQALDHSCS	MUC2	5106	Q02817
DHFPSLFCKEMSVGY	PDPR	646	Q8NCN5
YDAFESKHSCTLVME	MYLK3	576	Q32MK0
AHIPKSDALYFDDCM	NFE2L2	106	Q16236
TFCFHGNDTSMDALK	PRAMEF18	381	Q5VWM3
EMDCFFPLVKDAYSH	KALRN	1716	O60229
GKRHLFIMCSYCSTD	RSKR	176	Q96LW2
SSNFVAGDKDMYVCH	LCT	51	P09848
CHFDMAVYLASGNVS	LAMB2	356	P55268
YMCEHEGCSKAFSNA	GLI1	331	P08151
SKAAADLMAYCEAHA	GNG2	31	P59768
HAGMSTLFLVYSNKC	F8	2026	P00451
FGMCLSAEHAGLSEY	LONRF2	576	Q1L5Z9
SAYIVAVYHCMKDGL	POLE	2001	Q07864
ASRYGALVFMDECHA	GCAT	221	O75600
CAHCKNTMAYIGFVE	PDLIM5	446	Q96HC4
YHFSFLMAAVHCAAK	MRGPRE	251	Q86SM8
SSCLKSMEYFDPHTN	KLHL4	581	Q9C0H6
SCCHFMVKLLDDGTF	HSH2D	76	Q96JZ2
MYECKVCGETFLHSS	PEG3	626	Q9GZU2
TSCGDLHSVMLEYTK	RELN	3131	P78509
VKFNDAGEYHCMVSS	HMCN1	581	Q96RW7
ELSDMVIYCKSVHFG	PLCD1	491	P51178
QASVCHKAYSEMGLL	PALB2	1056	Q86YC2
TYCPHAKFLMTADDD	B3GNT5	181	Q9BYG0
CMKSLGSADELFKHY	EEA1	46	Q15075
FCAGMHSDHPKEYVT	ADAMTS9	1766	Q9P2N4
VMTEDAGDYTCKFIH	IL1RL1	171	Q01638
KMTAYGAFLHKGSFC	CACNA1C	971	Q13936
KNGDFSEAAMCYVHV	DOCK11	1631	Q5JSL3
VKNGDLSEAAMCYVH	DOCK9	1626	Q9BZ29
HCVATGYMCKSELSA	BAMBI	36	Q13145
TACKMDHYVATTEFL	CENPL	226	Q8N0S6
KHSYGMLFCSCRDIA	GFRA1	206	P56159
HECGAAFTSKLEGMF	CUL4A	481	Q13619
HTYAACTFLAASMKE	POLQ	551	O75417
ISKDHMNSISFYDGD	DNAAF9	581	Q5TEA3
YTMDCHRAKASLAGT	MS4A6E	106	Q96DS6
MVNFDGYSACDHTSK	EFNA5	81	P52803
CAMISAHYGLSDVFD	GBF1	961	Q92538
EKHSFLDCFMAFGSG	CYP39A1	396	Q9NYL5
HCYKDLGFMDFICSL	HEATR1	181	Q9H583
AECHYSMKKAASFLG	GADL1	216	Q6ZQY3
LTDMTLLHYACKAGA	CLIP3	116	Q96DZ5
KLMHLFTSGDCKAYS	GEMIN6	81	Q8WXD5
SLSGGASYVDFLCHM	SEC24C	1071	P53992
ADCCMRQGSYHLATK	IFT140	1196	Q96RY7
FDKLSESGFHMVACS	KCTD12	281	Q96CX2
ALEEIHKFSGTYTCM	DHRS3	281	O75911
SCKFHMENGTSVVYA	OTOGL	2191	Q3ZCN5
EFMHSVENVCGCAKY	OTOG	2666	Q6ZRI0
SGKDSLMLACYAGHL	FANK1	176	Q8TC84
GSDEVLFKVYCMDHT	RAPGEF4	666	Q8WZA2
AYGSAKDLICTHFMD	STRADA	151	Q7RTN6
CGKIFSDQETFYSHM	PRDM14	551	Q9GZV8
DYDDGFSMKHTATAR	SMARCE1	181	Q969G3
TSMHFDCGLKGNKSY	NHS	786	Q6T4R5
YSGSQLFEMHEKLSC	RIF1	2436	Q5UIP0
APKTTAEAYHAGMCS	RECQL4	736	O94761
FYANEAKCDSHMETF	PRODH	201	O43272
DNDQLAYSCFSHLMK	SGSM2	851	O43147
ALCYAAAAGHMKLVC	TANC1	971	Q9C0D5
DMLLSFAHACTLSDY	MSH4	621	O15457
MIFSYCSHGDLHEFL	ROR2	551	Q01974
DNRKVSFHMEYSCGT	SPSB3	121	Q6PJ21
CTGYIDHDISMFKAP	ODF3L1	51	Q8IXM7
KEAMTSDGYTALHLA	RIPK4	711	P57078
HSDCAFMVDNKAIYD	TUBA4B	136	Q9H853
MCLYGNHKTSAFLGF	ALG10	166	Q5BKT4
YTEHGKTCDMSFFIT	ZNF37A	176	P17032
EVFKESLMLQCGHSY	TRIM74	21	Q86UV6
TKPSAHMSDAAEYFC	TRAV8-4	96	P01737
AAAHYKCMLFSSGTV	PHF6	236	Q8IWS0
TKPSAHMSDAAEYFC	TRAV8-2	96	A0A0B4J237
LLSHMCGLFYFSDEK	TRAM1L1	231	Q8N609
SQLAFYHCMEKSGQD	SPEN	591	Q96T58
AGYCMEFKTESLTPH	SBSPON	166	Q8IVN8
THGKMCISENYICFA	TBC1D8B	316	Q0IIM8
HVLCMAISSDGKYLA	RRP9	201	O43818
YASHKEKEMVAGLFC	RYR3	2891	Q15413
CGKSYSSEESFKAHM	ZNF408	386	Q9H9D4
DSQHYMALLCFKNGS	XYLB	326	O75191
HAGKHMEDCIVASYT	WAPL	1111	Q7Z5K2
GTYSKIMDHKNSLCF	ROCK2	301	O75116
EMLSFDGHKLGYCSK	TAMM41	346	Q96BW9
KCMYCGHSFESLQDL	TSHZ3	276	Q63HK5
DFYSGECIAKMFGHS	WDR62	701	O43379
IACYSNMGFHDKVLE	ZC3H7A	96	Q8IWR0
YSCHDCGEDIMKVSL	ZNF112	231	Q9UJU3
GEYAACQSHAFMKGV	TMEM141	21	Q96I45
EVFKESLMLQCGHSY	TRIM73	21	Q86UV7
DTFTYKAHILCGNLM	PLEKHG1	356	Q9ULL1
PTCHYSFLTASAMKD	ZNF407	1661	Q9C0G0
KDTLEGDNMYTCSHC	USP34	2051	Q70CQ2
CHTTKMYSTDDGVQF	EFTUD2	476	Q15029
THVAFDCMKNYLDAI	AGPAT5	211	Q9NUQ2
VFSGLIMYSHFKDCD	SLC5A12	291	Q1EHB4
YMCFHDEIKGSITLN	SLC36A4	326	Q6YBV0
HACFTASLAMKYSDV	TRPM7	51	Q96QT4
FYSGEKAMTNHCKST	ZNF638	1936	Q14966
MHYSKISAGADQALA	TNS2	246	Q63HR2
HKMCEDDSRSYASSF	WWC3	61	Q9ULE0
ESSKMDFILSHAVYC	UGGT1	866	Q9NYU2
HFCGVAEMKSAVDYN	YTHDF2	466	Q9Y5A9
YECMNCGKSFSRVSH	ZNF181	321	Q2M3W8
EYDSMTLVHKFACKF	TRIM16L	296	Q309B1
HKAVLAACSDYFRAM	KLHL32	56	Q96NJ5
GSFEDPYHSHCMKVT	NEB	436	P20929